Brainstorm Cell Therapeutics Inc. (BCLI) Kompaniya qiymatining sof foydaga nisbati
GURU.Markets platformasida pul formatida vizuallashtirilgan Brainstorm Cell (BCLI) uchun bozor tendentsiyasi, u yerda ko'rsatkich -0.70 darajasida turibdi, asab kasalliklari uchun hujayrali davolashning rivojlanishini namoyish etmoqda. Biroq, global bo'linish va sanksiyalar transchegaraviy sinovlar hamda biomateriallar yetkazib berishga to'sqinlik qilmoqda. Shu bilan birga, Brainstorm Cell (BCLI) etika standartlariga qat'iy rioya qilmoqda va laboratoriya chiqindilarini kamaytirmoqda, bioreaktorlar bilan jihozlangan ishlab chiqarish korxonalari esa uzilishlarsiz ishlashda davom etmoqda.
%20P%2FE%20multiplikatori&width=1200&height=400&colorIndex=0&v=mwa76aez.ocr-7cpmfb4&start=20220704&end=20261110&filename=GURU_Markets_-_BCLI_-_Brainstorm-Cell_-_PE-Multiple "BCLI: BrainStorm Cell Therapeutics Inc. P/E multiplikatori 04.07.2022 - 26.07.2025 | 👁️GURU.Markets👁️")
Brainstorm Cell kompaniyasining tahliliy kesimlari
- kotirovkalar va tahlilchilar prognozi:
- bozor kapitallashuvi tafsilotlari:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Qarzning xususiy kapitalga nisbati Brainstorm Cell|BCLI - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga koeffitsiyenti BrainStorm Cell Therapeutics Inc.|BCLI - Kompaniyaning umumiy qarzi|Qarzning balans kapitaliga nisbati Brainstorm Cell Therapeutics Inc.|BCLI - Kompaniyaning uzoq muddatli qarzi|Qisqa muddatli qarz BrainStorm Cell Therapeutics|Oraliq qoplash koeffitsiyenti brainstorm-cell.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
BCLI - Kompaniyaning sof foydasi|Kelajakdagi foyda Brainstorm Cell|BCLI - Narx-foyda koeffitsiyenti|Kelajakdagi narx-foyda multiplikatori Brainstorm Cell Therapeutics Inc.|BCLI - PEG multiplikatori|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati koeffitsiyenti Brainstorm Cell Therapeutics Inc.|BCLI - EBITDA operatsion foydasi|So'nggi o'n ikki oy davomida bitta aksiya uchun sof foyda BrainStorm Cell Therapeutics|BCLI - So'nggi o'n ikki oy davomida bir aksiya uchun foyda|So'nggi o'n ikki oy davomida bir aksiya uchun foydaning yillik o'sishi brainstorm-cell.com|BCLI - Joriy yilda bir aksiya uchun foyda o'sishi|Keyingi yil uchun bir aksiya uchun sof foyda o'sishi prognozi Brainstorm Cell
Kompaniyaning umumiy tahlili:brainstorm-cell.com, BCLI
Investorlar Brainstorm Cell (BCLI) salohiyatini narx-foyda koeffitsiyenti prizmasi orqali bahlamoqdalar. Ushbu koeffitsient bozor kapitalizatsiyasini biznesning haqiqiy daromadlari bilan solishtirish orqali investitsiyalarning qoplash muddatini belgilaydi. Kompaniyaning bazaviy P/E koeffitsiyentini tahlil qilish likvidlik past bo'lgan davrlarda aktiv uchun haddan tashqari ko'p to'lov qilinganini aniqlash imkonini beradi. NurOwn platformasiga ega brend uchun ushbu ko'rsatkich terapevtik muvaffaqiyat va moliyaviy daromad o'rtasidagi muvozanatni aks ettiradi. Ushbu metrikaning aniq dinamikasi emitentning fundamental barqarorligini tasdiqlaydi.
Raqobatdosh kompaniyalar tahlili
Narxning foydaga nisbati BIIB|Narxning foydaga nisbati Neurocrine Biosciences, Inc. (NBIX)|RGC (Regencell Bioscience Ltd) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori AXSM (Axsome Therapeutics Inc)|P/E multiplikatori ACADIA Corp ACAD|Xenon Pharmaceuticals - P/E multiplikatori|Biznesning o‘zini qoplash muddati vikingtherapeutics.com VKTX|Supernus (SUPN) - Narxning foydaga nisbati|Narx-foyda multiplikatori CPRX|Narxning foydaga nisbati Denali Therapeutics Inc|Harmony Corp (HRMY) - Biznesning o‘zini qoplash muddati|Narx-foyda koeffitsiyenti BHVN (Biohaven Ltd.)|Bozor narxining sof foydaga nisbati AMLX|Narxning foydaga nisbati Trevi Therapeutics, Inc. TRVI|Praxis Precision Medicines Inc (PRAX) - Kapitalizatsiyaning foydaga nisbati|AVXL - Narxning foydaga nisbati|Kompaniya qiymatining sof foydaga nisbati CBLL (CeriBell EEG)|prothena.com (PRTA) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Alector|Narx-foyda koeffitsiyenti ANNX|OMER: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori NGNE|Narx-foyda koeffitsiyenti AC Immune Inc ACIU|P/E multiplikatori VYGR (Voyager Therapeutics)|neumoratx.com (NMRA) - Kapitalizatsiyaning foydaga nisbati|SCLX - Narxning foydaga nisbati|TVGN: Narxning foydaga nisbati|alphacognition.com (ACOG) - Narxning foydaga nisbati|CGTX (Cognition Therapeutics Inc.) - Narxning foydaga nisbati|IKT (Inhibikase Therapeutics) - P/E multiplikatori|Narxning foydaga nisbati SAVA|P/E multiplikatori ASRT|Narx-foyda koeffitsiyenti coyatherapeutics.com COYA|Narxning foydaga nisbati Vistagen VTGN|Ovid Therapeutics Inc - Narxning foydaga nisbati|Acumen Pharmaceuticals - P/E multiplikatori|Biznesning o‘zini qoplash muddati cervomed.com CRVO|alteritytherapeutics.com (ATHE) - Narxning foydaga nisbati|Narx-foyda multiplikatori CLNN|PEPG (PepGen Inc) - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Jupiter Neurosciences, Inc. JUNS|Narx-foyda koeffitsiyenti RLMD (Relmada Therapeutics)|P/E multiplikatori annovisbio.com (ANVS)|Narxning foydaga nisbati Grace Therapeutics GRCE|Kompaniya qiymatining sof foydaga nisbati AIFF|KLTO - Narxning foydaga nisbati|Kapitalizatsiyaning foydaga nisbati NeuroSense Therapeutics|RVPH: P/E multiplikatori|MTVA (MetaVia) - Narxning foydaga nisbati|Narxning foydaga nisbati NeurAxis|HSDT: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori PASG|P/E multiplikatori bionomics.com.au (NEUP)|P/E multiplikatori NERV (Minerva Neurosciences)|Biznesning o‘zini qoplash muddati athira.com (ATHA)|ADXN - Narxning foydaga nisbati|ALZN (Alzamend Neuro, Inc.) - Narx-foyda multiplikatori|cyclerion.com (CYCN) - Narxning foydaga nisbati|PTIX - Biznesning o‘zini qoplash muddati|Narx-foyda koeffitsiyenti KTTA|CRGT (Cortigent Medical) - Bozor narxining sof foydaga nisbati|Narxning foydaga nisbati Avenue Therapeutics, Inc. (ATXI)|CARA - Kapitalizatsiyaning foydaga nisbati|Narxning foydaga nisbati Chromocell Therapeutics Corporation CHRO|Kompaniya qiymatining sof foydaga nisbati ELYM|ITCI - Narxning foydaga nisbati|longboardpharma.com (LBPH) - Narx-foyda koeffitsiyenti|MRNS (Marinus Pharmaceuticals, Inc.) - Narx-foyda koeffitsiyenti|NKGen Biotech Inc - Kompaniya qiymatining sof foydaga nisbati|NRBO (NeuroBo) - P/E multiplikatori|Narx-foyda koeffitsiyenti Sage Therapeutics Inc (SAGE)|P/E multiplikatori SNPX|TRVN - Kapitalizatsiyaning foydaga nisbati|Narxning foydaga nisbati Vigil Neuroscience, Inc. VIGL|anewmeds.com - Narxning foydaga nisbati|CERE - Narxning foydaga nisbati
